Filing metadata

Accession number
0001683168-22-003054
Form type
Form 4
Filer
CNS Pharmaceuticals, Inc.
CIK
CIK 1729427
Filed
Apr 29, 2022
Reporting period
Apr 28, 2022
Description
Insider transaction

Explore SEC Filings Hub